Evidence map›Paper›PMID 22858643›Full record

ArticleSmall GTPases

ROCKs cause SHP-wrecks and broken hearts.

Panna Tandon, Frank L Conlon, Joan M Taylor

Abstract read
In one paragraph

Article in Small GTPases. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Panna TandonDepartment of Genetics, University of North Carolina, Chapel Hill, NC, USA.
Frank L Conlon
Joan M Taylor

Funding

FAK Signaling in cardiac growth and hypertrophyR01HL081844 · NHLBI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI TAYLOR, JOAN M · 2005 to 2013
$2.6M
Craniofacial and cardiac development in Xenopus: A genetic approachR01DE018825 · NIDCR · UNIV OF NORTH CAROLINA CHAPEL HILL · PI CONLON, FRANK LEO, KHOKHA, MUSTAFA K · 2009 to 2013
$2.3M
TBX5 and cardiac proliferationR01HL089641 · NHLBI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI CONLON, FRANK LEO · 2008 to 2011
$1.5M
Adhesion Signaling in Vascular Growth and DevelopmentR01HL071054 · NHLBI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI TAYLOR, JOAN M. · 2003 to 2006
$1.2M
NHLBI NIH HHS HL-071054NHLBI NIH HHS HL-081844NHLBI NIH HHS HL-089641NHLBI NIH HHS R01 HL071054NHLBI NIH HHS R01 HL081844NHLBI NIH HHS R01 HL089641NIDCR NIH HHS DE-018825NIDCR NIH HHS R01 DE018825
6 · The paper itself

Abstract

During embryogenesis, the heart is one of the first organs to develop. Its formation requires a complex combination of migration of cardiac precursors to the ventral midline coupled with the fusion of these cardiogenic fields and subsequent cellular reorganization to form a linear heart tube. A finely controlled choreography of cell proliferation, adhesion, contraction and movement drives the heart tube to loop and subsequently septate to form the four-chambered mammalian heart we are familiar with. Defining how this plethora of cellular processes is controlled both spatially and temporally is a scientific feat that has fascinated researchers for decades. Unfortunately, the complex nature of this organ's development also makes it a prime target for mutation-induced malformation, as evidenced by the multitude of prevalent congenital heart disorders identified that afflict up to 1% of the population.

Indexed as

1-(5-Isoquinolinesulfonyl)-2-MethylpiperazineAnimalsHeart Defects, CongenitalHumansMutationProtein Kinase InhibitorsProtein Tyrosine Phosphatase, Non-Receptor Type 11rho-Associated Kinases1-(5-Isoquinolinesulfonyl)-2-MethylpiperazinefasudilProtein Kinase InhibitorsProtein Tyrosine Phosphatase, Non-Receptor Type 11rho-Associated Kinases

Identifiers

PMID22858643
PMCPMC3520883

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.